Renin-angiotensin system inhibition prevents type 2 diabetes mellitus

This publication has 50 references indexed in Scilit:

• Antihypertensive Therapy and Incidence of Type 2 Diabetes
  Diabetes Care, 2004
• Prevention of Type 2 Diabetes Mellitus Through Inhibition of the Renin-Angiotensin System
  Drugs, 2004
• Newly Recognized Components of the Renin-Angiotensin System: Potential Roles in Cardiovascular and Renal Regulation
  Endocrine Reviews, 2003
• Management of Hypertension in Patients with Type 2 Diabetes Mellitus: Guidelines Based on Current Evidence
  Annals of Internal Medicine, 2001
• Diabetes, Hypertension, and Cardiovascular Disease
  Hypertension, 2001
• Hypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes Mellitus
  New England Journal of Medicine, 2000
• Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
  The Lancet, 1999
• Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial
  The Lancet, 1999
• Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease
  Diabetes Care, 1991
• Banting lecture 1988. Role of insulin resistance in human disease
  Diabetes, 1988